| Literature DB >> 21880430 |
A Spickett1, J F de Villiers, J Boomker, J B Githiori, G F Medley, M O Stenson, P J Waller, F J Calitz, A F Vatta.
Abstract
Haemonchosis is considered to be the most economically important gastrointestinal disease of small ruminants in the tropics and subtropics. However, chemical anthelmintics, which were the mainstay of control, have been compromised by a high prevalence of resistance worldwide. Copper oxide wire particles (COWP) have been shown to have anthelmintic effects, but few studies have examined their use under field conditions. The use of COWP was therefore evaluated as a tactical anthelmintic treatment in indigenous goats raised under communal farming conditions in Bergville, KwaZulu-Natal Province, South Africa. At the beginning of the summer rainfall season (October 2007), the faecal egg counts of 172 female goats belonging to 15 farmers were determined and this sampling continued every four weeks until the second week of January 2008. The goats within each of the 15 herds were ranked according to their faecal egg counts for this week. The goats were sequentially paired off within each ranking starting with those goats with the highest counts. One goat from each pair was randomly allocated to a treated or control group. Two weeks later, a 4 g COWP bolus was randomly administered to each goat in the treated group. Faecal egg counts were carried out on the goats two weeks following treatment, and the sampling of the goats then proceeded every four weeks until October 2008. Except for the six-week period prior to the administration of the COWP, the goats were examined according to the FAMACHA(©) system and symptomatically treated with 12 mg/kg levamisole when anaemic. The percentage reduction in faecal egg count due to the COWP treatment was 89.0%. Mean pre- and post-treatment faecal egg counts for the COWP-treated group (n=73) were 2347 eggs per gram of faeces (epg) and 264 epg, respectively. The corresponding values for the untreated controls (n=66) were 2652 epg and 2709 epg. The prevalence of Haemonchus spp. larvae in pre- and post-treatment faecal cultures was 72% and 46%, respectively. Symptomatic anthelmintic treatments in combination with mid-summer tactical treatments with COWP appear to be useful strategies for the control of Haemonchus contortus in indigenous goats in this farming system and this approach could have application in other similar agro-ecological zones.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21880430 PMCID: PMC3336207 DOI: 10.1016/j.vetpar.2011.08.003
Source DB: PubMed Journal: Vet Parasitol ISSN: 0304-4017 Impact factor: 2.738
Fig. 1Study area: localities of homesteads near Bergville in KwaZulu-Natal Province, with the adjacent provinces of the Free State and Eastern Cape shown.
Fig. 2Mean average rainfall (columns) and minimum (▵) and maximum (■) temperatures in the Bergville area throughout the trial period.
Fig. 3Mean faecal egg counts (FECs) for the control and COWP-treated goats combined for all three trial areas. The error bars indicate the standard error.
The analysis of variance table (ANOVA) for pre- and three periods post-COWP administration for log10 faecal egg counts.
| Source | 22 January 2008 | 5 February 2008 | 4 March 2008 | 1 April 2008 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| d.f. | m.s. | F pr. | d.f. | m.s. | F pr. | d.f. | m.s. | F pr. | d.f. | m.s. | F pr. | |
| Area | 2 | 0.186 | 0.819 | 2 | 6.476 | 0.004 | 2 | 0.178 | 0.650 | 2 | 4.126 | 0.016 |
| Treat | 1 | 1.013 | 0.298 | 1 | 35.335 | <.001 | 1 | 0.030 | 0.787 | 1 | 1.266 | 0.256 |
| Age | 1 | 0.079 | 0.771 | 1 | 1.534 | 0.251 | 1 | 4.016 | 0.002 | 1 | 7.088 | 0.008 |
| Area × Treat | 2 | 0.300 | 0.728 | 2 | 0.572 | 0.610 | 2 | 0.180 | 0.646 | 2 | 0.753 | 0.464 |
| Area × Age | 2 | 0.029 | 0.969 | 2 | 2.202 | 0.152 | 2 | 0.032 | 0.925 | 2 | 0.654 | 0.513 |
| Treat × Age | 1 | 0.063 | 0.794 | 1 | 0.667 | 0.448 | 1 | 0.141 | 0.559 | 1 | 0.843 | 0.354 |
| Area × Treat × Age | 2 | 0.257 | 0.759 | 2 | 0.058 | 0.951 | 2 | 0.098 | 0.789 | 2 | 0.658 | 0.511 |
| Residual | 154 | 0.928 | 156 | 1.154 | 155 | 0.411 | 160 | 0.975 | ||||
| Total | 165 | 0.882 | 167 | 1.141 | 156 | 0.415 | 171 | 1.038 | ||||
| Levene's test | ||||||||||||
Treatment.
d.f. = degrees of freedom.
m.s. = mean square.
F pr. = Type I probability for variance ratio.
Main effect means for pre- and three periods post-COWP administration for log10 faecal egg counts, original mean count and number of animals sampled (n).
| Source effect | Levels | 22 January 2008 | 5 February 2008 | 4 March 2008 | 1 April 2008 |
|---|---|---|---|---|---|
| Area (Bergville) | Dukuza | 2.793 (2020) | 2.552a (1441) | 3.006 (2177) | 2.559a (1567) |
| Hoffenthal | 2.876 (1911) | 2.004b (913) | 3.011 (1798) | 2.499ab (936) | |
| Ogade | 2.949 (2202) | 1.988b (1549) | 2.950 (2000) | 2.097b (486) | |
| Treatment | Control | 2.768 (2158) | 2.716a (2382) | 2.960 (2247) | 2.487 (1346) |
| COWP | 2.949 (1910) | 1.747b (223) | 3.024 (1783) | 2.351 (825) | |
| Age | Young | 2.956(1857) | 1.883 (1509) | 3.354a (2958) | 2.880a (2474) |
| Adult | 2.841 (2067) | 2.298 (1263) | 2.922b (1831) | 2.329b (812) | |
Means within the same source effect with the same letter or letters do not differ significantly at the 5% significance level. No letters means no significant difference.
The calculated percentage efficacy, mean FECs (range) pre- and post-COWP administration and number of animals sampled (n) for the control (C) and treated (COWP) groups of goats per area and age group.
| Area | Goat age group | Mean FEC pre-COWP | Mean FEC post-COWP | Calculated % efficacy | ||
|---|---|---|---|---|---|---|
| C | COWP | C | COWP | |||
| All | All | 2652 | 2347 | 2709 | 264 | 89 |
| (200–11533) | (200–13300) | (0–14433) | (0–1800) | |||
| All | Young | 2572 | 1591 | 2736 | 246 | 85.5 |
| (200–8433) | (237–5133) | (0–9167) | (0–867) | |||
| All | Adults | 2669 | 2482 | 2703 | 267 | 89.4 |
| (267–11533) | (200–13300) | (0–14433) | (0–1800) | |||
| Hoffenthal | All | 2512 | 2114 | 2221 | 165 | 91.2 |
| (267–10833) | (200–2233) | (0–14433) | (0–567) | |||
| Hoffenthal | Young | 1478 | 1093 | 1689 | 200 | 84 |
| (367–3467) | (267–2233) | (33–4867) | (0–567) | |||
| Hoffenthal | Adults | 2706 | 2383 | 2321 | 156 | 92.4 |
| (267–10833) | (200–533) | (0–14433) | (0–100) | |||
| Ogade | All | 2737 | 2419 | 3489 | 130 | 95.8 |
| (200–6667) | (567–4267) | (0–7133) | (0–167) | |||
| Ogade | Young | 3878 | 4267 | 1756 | 0 | 100 |
| (200–6467) | -4267 | (0–5267) | 0 | |||
| Ogade | Adults | 2509 | 2317 | 3836 | 137 | 96.1 |
| (633–6667) | (567–1867) | (0–7133) | (100–167) | |||
| Dukuza | All | 2690 | 2489 | 2545 | 428 | 81.8 |
| (333–11533 | (237–13300) | (0–11667) | (0–1800) | |||
| Dukuza | Young | 2467 | 1553 | 3750 | 340 | 85.6 |
| (600–8433) | (237–5133) | (167–9167) | (0–867) | |||
| Dukuza | Adults | 2748 | 2676 | 2230 | 445 | 79.5 |
| (333–11533) | (1967–13300) | (0–11667) | (167–1800) | |||
Fig. 4Percentage of nematode larvae recovered from faecal cultures, averaged for all three trial areas, identified as Haemonchus (solid black columns), Oesophagostomum (diagonally striped columns), Teladorsagia/Trichostrongylus (white columns) and Strongyloides (horizontally striped columns) for each sampling occasion of the trial period.
Fig. 5Mean PCV for the control and COWP-treated goats combined for all three trial areas. The error bars indicate the standard error.
The analysis of variance table (ANOVA) for pre- and three periods post-COWP administration for packed cell volume (PCV) in percentage.
| Source | 22 January 2008 | 5 February 2008 | 4 March 2008 | 1 April 2008 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| d.f. | m.s. | F pr. | d.f. | m.s. | F pr. | d.f. | m.s. | F pr. | d.f. | m.s. | F pr. | |
| Area | 2 | 8.25 | 0.519 | 2 | 93.00 | <.001 | 2 | 0.08 | 0.995 | 2 | 15.69 | 0.278 |
| Treat | 1 | 29.86 | 0.124 | 1 | 184.89 | <.001 | 1 | 70.53 | 0.028 | 1 | 15.97 | 0.254 |
| Age | 1 | 23.32 | 0.174 | 1 | 0.42 | 0.843 | 1 | 9.62 | 0.414 | 1 | 14.86 | 0.271 |
| Area × Treat | 2 | 16.00 | 0.281 | 2 | 0.39 | 0.964 | 2 | 10.20 | 0.493 | 2 | 17.19 | 0.247 |
| Area × Age | 2 | 25.97 | 0.129 | 2 | 24.50 | 0.106 | 2 | 29.55 | 0.131 | 2 | 7.05 | 0.562 |
| Treat × Age | 1 | 4.91 | 0.532 | 1 | 3.97 | 0.544 | 1 | 6.91 | 0.489 | 1 | 0.73 | 0.807 |
| Area × Treat × Age | 2 | 12.08 | 0.383 | 2 | 29.76 | 0.066 | 2 | 23.12 | 0.203 | 2 | 20.91 | 0.183 |
| Residual | 159 | 12.52 | 160 | 10.76 | 160 | 14.35 | 160 | 12.17 | ||||
| Total | 170 | 12.78 | 171 | 12.90 | 171 | 14.68 | 171 | 12.29 | ||||
| Levene's test | ||||||||||||
Treatment.
d.f. = degrees of freedom.
m.s. = mean square.
F pr. = Type I probability for variance ratio.
Main effect means for pre- and three periods post-COWP administration for PCV content and number of animals sampled (n).
| Source effect | Levels | 22 January 2008 | 5 February 2008 | 4 March 2008 | 1 April 2008 |
|---|---|---|---|---|---|
| Area (Bergville) | Dukuza | 25.26 | 24.96a | 25.45 | 26.1 |
| Hoffenthal | 25.98 | 27.28b | 25.41 | 26.96 | |
| Ogade | 25.18 | 25.25a | 24.8 | 26.35 | |
| Treatment | Control | 25.14 | 24.82b | 24.78b | 26.24 |
| COWP | 25.79 | 26.72a | 25.74a | 26.64 | |
| Age | Young | 25.63 | 25.38 | 23.93 | 25.35 |
| Adult | 25.44 | 25.86 | 25.52 | 26.66 | |
Means within the same source effect with the same letter or letters do not differ significantly at the 5% significance level. No letters means no significant difference.
Numbers of goats assigned a FAMACHA© score of 3, 4 or 5 and treated with 12 mg/kg levamisole at each visit for the control group and the COWP-treated group. (Total number of goats scored in each group in parenthesis.) COWP treatment was during the visit of 22 January 2008.
| Date | 16 October 2007 | 13 November 2007 | 11 December 2007 | 08 January 2008 | 22 January 2008 | 05 February 2008 | 04 March 2008 | 01 April 2008 | 29 April 2008 | 27 May 2008 | 24 June 2008 | 22 July 2008 | 19 August 2008 | 16 September 2008 | 14 October 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | 66 (85) | 45 (85) | 39 (85) | 21 (85) | 41 (84) | 42 (85) | 42 (85) | 42 (85) | 26 (82) | 47 (85) | 32 (85) | 24 (84) | 15 (84) | 10 (85) | 21 (84) |
| COWP | 68 (87) | 55 (87) | 40 (87) | 28 (87) | 46 (87) | 38 (87) | 48 (87) | 41 (87) | 41 (84) | 51 (87) | 32 (87) | 28 (87) | 16 (86) | 17 (84) | 31 (87) |
Fig. 6Box plots showing the relationship between PCV value and FAMACHA© score category for all animals assessed during the trial. High and low bounds are at the 90th and 10th percentiles. Dots represent individual values outside of this range. The line inside the box indicates the median.